The Strong Gut Study

Start date

Oct 08th, 11th, 12th

Remuneration

$6,250

3 night stay, 9 follow ups

Help Test a New Potential drug for the Treatment of IBD

This clinical study is evaluating a potential new drug for to treat IBD. IBD is a term used to describe conditions that cause abdominal pain and diarrhoea, among other symptoms. The study drug is designed to reduce the inflammatory response that causes IBD symptoms. The study is a randomised, double-blind, placebo-controlled trial. The purpose of this study is to assess the safety and tolerability of a single dose in healthy men and women with a BMI of 18–35.

Apply Now

young woman smiling with her arms crossed

Schedule

Cohort 5.1

3 Night Stay

Check In

Oct 08th

Check Out

Oct 11th

9 appointments

Oct 16th, 23rd, 30th, Nov 06th, 20th, Dec 04th, Jan 01st, 29th, Feb 26th

Cohort 5.2

3 Night Stay

Check In

Oct 11th

Check Out

Oct 14th

9 appointments

Oct 19th, 26th, Nov 02nd, 09th, 23rd, Dec 07th, Jan 04th, Feb 01st, Mar 01st

Cohort 5.3

3 Night Stay

Check In

Oct 12th

Check Out

Oct 15th

9 appointments

Oct 20th, 27th, Nov 03rd, 10th, 24th, Dec 08th, Jan 05th, Feb 02nd, Mar 02nd

To Qualify, You Must

Age

Be 18 to 55 years old

Gender

Both males or females

Physical Condition

Have no significant medical health conditions or allergies

Requirements

Have a BMI between 18 and 35kg/m2

Remuneration

$6,250

Help Test a New Treatment for IBD

Spots are limited. Find out if you qualify today!

Apply Now